vs

Side-by-side financial comparison of AMERISERV FINANCIAL INC (ASRV) and Spectral AI, Inc. (MDAI). Click either name above to swap in a different company.

Spectral AI, Inc. is the larger business by last-quarter revenue ($4.1M vs $3.9M, roughly 1.0× AMERISERV FINANCIAL INC). AMERISERV FINANCIAL INC runs the higher net margin — 36.9% vs 25.7%, a 11.2% gap on every dollar of revenue. On growth, AMERISERV FINANCIAL INC posted the faster year-over-year revenue change (2.4% vs -46.3%). Over the past eight quarters, Spectral AI, Inc.'s revenue compounded faster (-19.6% CAGR vs -46.6%).

Ameriserv Financial Inc. is a Pennsylvania-headquartered regional financial services holding company. It provides retail and commercial banking products including deposit accounts, loan products and wealth management solutions, serving individual consumers and SMEs across its local operating markets in the United States.

Spectral AI, Inc. is a medical technology firm specializing in AI-powered diagnostic imaging solutions primarily for burn and wound care. It develops non-invasive imaging tools that enable healthcare providers to deliver faster, more accurate treatment assessments, serving clinical and healthcare partner networks across North America and European markets.

ASRV vs MDAI — Head-to-Head

Bigger by revenue
MDAI
MDAI
1.0× larger
MDAI
$4.1M
$3.9M
ASRV
Growing faster (revenue YoY)
ASRV
ASRV
+48.7% gap
ASRV
2.4%
-46.3%
MDAI
Higher net margin
ASRV
ASRV
11.2% more per $
ASRV
36.9%
25.7%
MDAI
Faster 2-yr revenue CAGR
MDAI
MDAI
Annualised
MDAI
-19.6%
-46.6%
ASRV

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
ASRV
ASRV
MDAI
MDAI
Revenue
$3.9M
$4.1M
Net Profit
$1.4M
$1.1M
Gross Margin
45.2%
Operating Margin
43.0%
-54.9%
Net Margin
36.9%
25.7%
Revenue YoY
2.4%
-46.3%
Net Profit YoY
62.2%
113.9%
EPS (diluted)
$0.09
$0.04

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ASRV
ASRV
MDAI
MDAI
Q4 25
$3.9M
$4.1M
Q3 25
$15.4M
$3.8M
Q2 25
$14.5M
$5.1M
Q1 25
$14.1M
$6.7M
Q4 24
$3.8M
$7.6M
Q3 24
$13.1M
$8.2M
Q2 24
$13.2M
$7.5M
Q1 24
$13.7M
$6.3M
Net Profit
ASRV
ASRV
MDAI
MDAI
Q4 25
$1.4M
$1.1M
Q3 25
$2.5M
$-3.6M
Q2 25
$-282.0K
$-8.0M
Q1 25
$1.9M
$2.9M
Q4 24
$889.0K
$-7.6M
Q3 24
$1.2M
$-1.5M
Q2 24
$-375.0K
$-2.9M
Q1 24
$1.9M
$-3.2M
Gross Margin
ASRV
ASRV
MDAI
MDAI
Q4 25
45.2%
Q3 25
42.7%
Q2 25
45.2%
Q1 25
47.2%
Q4 24
44.0%
Q3 24
44.9%
Q2 24
44.3%
Q1 24
46.6%
Operating Margin
ASRV
ASRV
MDAI
MDAI
Q4 25
43.0%
-54.9%
Q3 25
20.0%
-88.1%
Q2 25
-2.4%
-41.9%
Q1 25
17.0%
-13.4%
Q4 24
28.2%
-14.6%
Q3 24
10.8%
-10.8%
Q2 24
-3.7%
-32.7%
Q1 24
17.4%
-33.9%
Net Margin
ASRV
ASRV
MDAI
MDAI
Q4 25
36.9%
25.7%
Q3 25
16.5%
-93.7%
Q2 25
-1.9%
-157.3%
Q1 25
13.6%
43.2%
Q4 24
23.3%
-99.8%
Q3 24
9.0%
-18.4%
Q2 24
-2.8%
-38.3%
Q1 24
13.9%
-50.7%
EPS (diluted)
ASRV
ASRV
MDAI
MDAI
Q4 25
$0.09
$0.04
Q3 25
$0.15
$-0.13
Q2 25
$-0.02
$-0.31
Q1 25
$0.12
$0.11
Q4 24
$0.05
$-0.42
Q3 24
$0.07
$-0.08
Q2 24
$-0.02
$-0.16
Q1 24
$0.11
$-0.19

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ASRV
ASRV
MDAI
MDAI
Cash + ST InvestmentsLiquidity on hand
$15.4M
Total DebtLower is stronger
$9.3M
Stockholders' EquityBook value
$119.3M
$-5.7M
Total Assets
$1.5B
$21.4M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ASRV
ASRV
MDAI
MDAI
Q4 25
$15.4M
Q3 25
$10.5M
Q2 25
$10.5M
Q1 25
$14.1M
Q4 24
$5.2M
Q3 24
$3.7M
Q2 24
$6.9M
Q1 24
$10.2M
Total Debt
ASRV
ASRV
MDAI
MDAI
Q4 25
$9.3M
Q3 25
Q2 25
Q1 25
$7.8M
Q4 24
$2.8M
Q3 24
$1.0M
Q2 24
Q1 24
Stockholders' Equity
ASRV
ASRV
MDAI
MDAI
Q4 25
$119.3M
$-5.7M
Q3 25
$114.6M
$-8.2M
Q2 25
$110.9M
$-9.2M
Q1 25
$110.8M
$-1.6M
Q4 24
$107.2M
$-7.3M
Q3 24
$108.2M
$-4.8M
Q2 24
$103.7M
$-4.7M
Q1 24
$103.9M
$-2.5M
Total Assets
ASRV
ASRV
MDAI
MDAI
Q4 25
$1.5B
$21.4M
Q3 25
$1.5B
$15.3M
Q2 25
$1.4B
$16.0M
Q1 25
$1.4B
$20.7M
Q4 24
$1.4B
$12.1M
Q3 24
$1.4B
$11.6M
Q2 24
$1.4B
$13.9M
Q1 24
$1.4B
$15.5M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ASRV
ASRV
MDAI
MDAI
Operating Cash FlowLast quarter
$3.2M
$-2.6M
Free Cash FlowOCF − Capex
FCF MarginFCF / Revenue
Capex IntensityCapex / Revenue
Cash ConversionOCF / Net Profit
2.21×
-2.43×
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ASRV
ASRV
MDAI
MDAI
Q4 25
$3.2M
$-2.6M
Q3 25
$1.4M
$-2.5M
Q2 25
$-62.0K
$-3.4M
Q1 25
$599.0K
$-1.5M
Q4 24
$2.7M
$469.0K
Q3 24
$-235.0K
$-1.6M
Q2 24
$1.7M
$-5.4M
Q1 24
$-2.2M
$-2.7M
Cash Conversion
ASRV
ASRV
MDAI
MDAI
Q4 25
2.21×
-2.43×
Q3 25
0.55×
Q2 25
Q1 25
0.31×
-0.52×
Q4 24
3.02×
Q3 24
-0.20×
Q2 24
Q1 24
-1.13×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ASRV
ASRV

Asset Management1$3.1M79%
Other$838.0K21%

MDAI
MDAI

Segment breakdown not available.

Related Comparisons